Vivo Capital, LLC

Palo Alto, CA · CIK 1674712 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2014 · limited liability company

Assets managed$6.1bn
Staff62 · 32 in investment roles
Main clients (by assets)Private funds 100%
Private funds16 · $6.5bn gross assets
Form ADV · 2026-03-31SEC adviser record

Legal entityVIVO CAPITAL LLC (US)

Kindprivate equity, venture, structured credit
Others nearbyPalo Alto, CA, Shanghai, Beijing, Singapore, Taipei
FamilyVivo Capital, LLC · 2 related pages

As an employer

Offices in4 countries
Private fundsprivate equity 6, other private 3, venture capital 6, securitized asset 1

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

City	Country	People
Palo Alto, CA (main office)United States	United States	about 10
BeijingChina	China	15
ShanghaiChina	China	4
SingaporeSingapore	Singapore	2
Central, Hong KongChina	China	1
TaipeiTaiwan, Republic of China	Taiwan, Republic of China

US visa salary filings

Filings FY2024–20254
Median salary offered$133,110
Middle half$92,046 – $169,146
Job titles4

Job title	Filings	Median	Range
AssociatePalo Alto, CA	1	$169,146	$169,146 – $200,000
Principal, A Bio-Scientific Investment ProfessionalPalo Alto, CA	1	$169,146	$169,146 – $400,000
AnalystPalo Alto, CA	1	$97,074	$97,074 – $117,332
Graphic DesignerBoston, MA	1	$76,960	$76,960 – $90,021

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Vivo Capital, LLC, Vivo Capital,LLC.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.1bn reported value -9.0% vs Q1 2026

47positions

52.4%in top 10

7 new 6 added 8 reduced 6 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	TREVI THERAPEUTICS INC COM TRVI	TRVI	5,094,668	$95.0m8.68%	8.68%	Unchanged
2	PRAXIS PRECISION MEDICINES I COM NEW PRAX	PRAX	271,116	$90.8m8.29%	8.29%	Reduced -67.8k	-67,779 -20.0%
3	ERASCA INC COM ERAS	ERAS	4,127,412	$75.6m6.90%	6.90%	Reduced -8.0m	-8,024,068 -66.0%
4	ARRIVENT BIOPHARMA INC COM AVBP	AVBP	1,682,097	$58.4m5.34%	5.34%	Added +796.2k	+796,181 89.9%
5	ABIVAX SA SPONSORED ADS ABVX	ABVX	414,899	$55.3m5.05%	5.05%	Added +175.4k	+175,360 73.2%
6	TANGO THERAPEUTICS INC COM TNGX	TNGX	1,379,769	$43.1m3.94%	3.94%	Reduced -775.0k	-775,011 -36.0%
7	CORVUS PHARMACEUTICALS INC COM CRVS	CRVS	2,805,816	$41.9m3.83%	3.83%	Unchanged
8	BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG	DRUG	557,172	$39.1m3.57%	3.57%	Unchanged
9	SINOVAC BIOTECH LTD SHS SVA	SVA	5,903,000	$38.2m3.49%	3.49%	Unchanged
10	TENAX THERAPEUTICS INC COM NEW TENX	TENX	2,500,000	$36.4m3.32%	3.32%	Added +2.3m	+2,291,667 1100.0%
11	ACLARIS THERAPEUTICS INC COM ACRS	ACRS	6,694,637	$35.4m3.23%	3.23%	Added +28.0k	+27,971 0.4%
12	DYNE THERAPEUTICS INC COM DYN	DYN	1,557,466	$34.6m3.16%	3.16%	Unchanged
13	DIANTHUS THERAPEUTICS INC COM DNTH	DNTH	353,998	$34.5m3.15%	3.15%	Unchanged
14	ALTO NEUROSCIENCE INC COM SHS ANRO	ANRO	1,208,858	$31.9m2.91%	2.91%	Added +173.3k	+173,307 16.7%
15	DBV TECHNOLOGIES S A SPONSORED ADS DBVT	DBVT	1,844,758	$30.3m2.76%	2.76%	Reduced -822.8k	-822,811 -30.8%
16	SAB BIOTHERAPEUTICS INC COM NEW SABS	SABS	7,299,909	$28.5m2.60%	2.60%	Reduced -4.1m	-4,120,091 -36.1%
17	MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX	MLTX	1,400,000	$27.3m2.49%	2.49%	Added +400.0k	+400,000 40.0%
18	LB PHARMACEUTICALS INC COM SHS LBRX	LBRX	800,000	$26.0m2.37%	2.37%	Unchanged
19	MINERVA NEUROSCIENCES INC COM NEW NERV	NERV	4,322,747	$24.0m2.19%	2.19%	Unchanged
20	DESIGN THERAPEUTICS INC COM DSGN	DSGN	1,612,903	$23.3m2.13%	2.13%	Unchanged
21	ORIC PHARMACEUTICALS INC COM ORIC	ORIC	1,848,786	$20.0m1.83%	1.83%	Unchanged
22	CAMP4 THERAPEUTICS CORP COM CAMP	CAMP	4,246,568	$18.6m1.69%	1.69%	Unchanged
23	FAETH THERAPEUTICS INC COM NEW FTH	FTH	722,020	$18.1m1.65%	1.65%	Unchanged
24	ACHIEVE LIFE SCIENCES INC COM ACHV	ACHV	2,751,032	$18.0m1.64%	1.64%	New
25	COMPASS THERAPEUTICS INC COM CMPX	CMPX	7,757,060	$17.0m1.55%	1.55%	Reduced -1.8m	-1,788,406 -18.7%
26	AN2 THERAPEUTICS INC COM ANTX	ANTX	3,153,640	$15.3m1.39%	1.39%	Unchanged
27	EDITAS MEDICINE INC COM EDIT	EDIT	3,555,250	$11.5m1.05%	1.05%	New
28	GERON CORP COM GERN	GERN	8,671,797	$11.1m1.01%	1.01%	Unchanged
29	ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX	ODTX	575,000	$10.8m0.98%	0.98%	New
30	EUPRAXIA PHARMACEUTICALS INC COM EPRX	EPRX	1,350,000	$8.9m0.81%	0.81%	Unchanged
31	ONKURE THERAPEUTICS INC COM CL A OKUR	OKUR	1,927,710	$8.8m0.80%	0.80%	Unchanged
32	OLEMA PHARMACEUTICALS INC COM OLMA	OLMA	671,843	$8.4m0.77%	0.77%	Unchanged
33	MONOPAR THERAPEUTICS INC COM NEW MNPR	MNPR	90,500	$8.4m0.77%	0.77%	Unchanged
34	AURA BIOSCIENCES INC COM AURA	AURA	1,166,667	$8.3m0.76%	0.76%	New
35	SURROZEN INC COM NEW SRZN	SRZN	260,000	$6.7m0.62%	0.62%	Unchanged
36	ALX ONCOLOGY HLDGS INC COM ALXO	ALXO	3,184,713	$6.6m0.60%	0.60%	Unchanged
37	SATELLOS BIOSCIENCE INC COM MSLE	MSLE	813,666	$6.3m0.58%	0.58%	Unchanged
38	AVALO THERAPEUTICS INC COM NEW AVTX	AVTX	275,000	$5.1m0.46%	0.46%	New
39	PEPGEN INC COM PEPG	PEPG	2,325,000	$4.2m0.38%	0.38%	Unchanged
40	VALNEVA SE SPONSORED ADS VALN	VALN	763,199	$4.0m0.36%	0.36%	New
41	SERA PROGNOSTICS INC CLASS A COM SERA	SERA	1,650,440	$3.0m0.27%	0.27%	Unchanged
42	UNICYCIVE THERAPEUTICS INC COM NEW UNCY	UNCY	550,000	$2.6m0.24%	0.24%	Reduced -1.2m	-1,239,916 -69.3%
43	INSTIL BIO INC COM NEW TIL	TIL	292,743	$2.3m0.21%	0.21%	Unchanged
44	INMED PHARMACEUTICALS INC COM NEW INM	INM	798,377	$1.2m0.11%	0.11%	New
45	BOLT BIOTHERAPEUTICS INC COM NEW BOLT	BOLT	72,414	$278.8k0.03%	0.03%	Unchanged
46	PASITHEA THERAPEUTICS CORP COM NEW KTTA	KTTA	465,471	$239.9k0.02%	0.02%	Reduced -1.6m	-1,634,529 -77.8%
47	PRECISION BIOSCIENCES INC COM NEW DTIL	DTIL	4,675	$36.7k0.00%	0.00%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
TERNS PHARMACEUTICALS INC		1,334,418	$70.4m1.3m shares
VERADERMICS INC MANE	MANE	300,000	$18.9m300.0k shares
COGENT BIOSCIENCES INC COGT	COGT	422,300	$16.3m422.3k shares
SOLENO THERAPEUTICS INC SLNO	SLNO	294,909	$9.9m294.9k shares
VIRIDIAN THERAPEUTICS INC VRDN	VRDN	166,288	$3.3m166.3k shares
COMPASS PATHWAYS PLC CMPS	CMPS	200,000	$1.1m200.0k shares